Safety and Performance Assessment of a First Four Arms on Demand Open Robotic Solution for Assisted PN, RN and RP

The Bitrack System is first 4-arms on demand open robotic platform indicated to be used during general abdominal laparoscopic urologic surgical procedures. This robot is intended to assist in the accurate control of endoscopic instruments and accessories for visualization and endoscopic manipulation.

The HYROS-PRnP clinical investigation was planned to be conducted in a single-center, with a single arm, open-label, and non-randomized design to include 15 patients. This clinical investigation aimed to evaluate the safety and performance of the Bitrack System in patients indicated with robotic-assisted laparoscopic Radical nephrectomy, Partial nephrectomy or Radical Prostatectomy surgeries.

The planned visits for this clinical investigation were Baseline (including Screening, Baseline visit, and Informed consent), Procedure, Discharge, 14-Days Follow-up visit (onsite), and 30-Days Follow-up visit (remote). The patient population were adult subjects (between 18 and 90 years old) who had been scheduled for laparoscopic Radical Nephrectomy. Partial Nephrectomy or Radical Prostatectomy. The expected duration of the clinical investigation was 4 months, consisting of approximately 3 months of enrollment plus 1 month of follow-up. The end of the clinical investigation would occur when the last visit of the last enrolled subject was completed.

Inclusion criteria

• Adult subjects between 18 and 90 years old who have provided written informed consent prior to any clinical investigation related procedures.
• Subjects who have been scheduled for a laparoscopic Radical/simple Nephrectomy surgery, laparoscopic Partial Nephrectomy or laparoscopic Radical Prostatectomy following the surgeon criteria.
• Ability and willingness to comply with all study requirements to be evaluated for each study visit.

Exclusion criteria

• Pregnant or breastfeeding women at the time of the surgery.
• Subjects with severe concomitant illness that, at PI´s discretion, increases risk of therapeutic interventions or that have been submitted to multiple prior surgeries.
• Subjects admitted to the hospital due to an emergency situation.
• Subjects with untreated active infection.
• Subject with known allergy to some of the device components (i.e., stainless steel, etc.)
• Subjects not suitable to undergo MIS/MIRS, according to medical criteria.
• Subjects with life expectancy inferior to 3 months.
• Subjects with a BMI ≥ 40.
• Subjects with any contraindication for the use of the Bitrack System and the ESE/NESE instruments, as specified in the Instructions For Use.
• Subjects with abuses of active substances or with uncontrolled psychiatric disorders.
• Subjects with severe cardiopulmonary or coronary artery disease, bleeding disorders or that have been submitted to multiple prior operations.
• Subjects scheduled for surgeries intended to be in direct contact with the heart, the central circulatory system or the central nervous system.
• Inability to adhere to study-related procedures.
• Subjects who participate in another trial which may affect the outcome data on this study or the ability to complete the follow up requirements.